2020 American Transplant Congress
Delayed Introduction of Mammalian Inhibitors of Rapamycin (mTOR) Post Kidney Transplantation Might Avoid the Chronic Nephrotoxicity of Calcineurin Inhibitors. Herein We Are Reporting an Eight-Years Single Center Experience of mTOR-Based Immunosuppression Regimen in Comparison with Cyclosporin-Based Regimen
*Purpose: Delayed introduction of mTOR inhibitors post kidney transplantation might avoid the chronic nephrotoxicity of CNI: eight-years single center experience.*Methods: This is a retrospective analysis…2020 American Transplant Congress
Validation of Patient Reported Outcomes Measurement Information System (PROMIS) Computer Adaptive Testing Depression Item Bank in Kidney Transplant Recipients
*Purpose: To evaluate the reliability and validity of the PROMIS Depression computerized adaptive test (PROMIS-D CAT) in relation to a legacy measure in adult Kidney…2020 American Transplant Congress
Living Donor Nephrectomy Outcomes in the Us: Analysis of HCUP Data
*Purpose: To identify clinical outcomes and complications of living donor nephrectomies in the US from 2008 - 2015.*Methods: A retrospective analysis of 2008-2015 discharge data…2020 American Transplant Congress
Comparison of Intraoperative Cortical Renal Blood Flow after Reperfusion Using Laser Speckle Flowgraphy Device between Adult and Pediatric Kidney Transplants
Nephrology, Toho University Faculty of Medicine, Tokyo, Japan
*Purpose: Laser speckle flowgraphy (LSFG) is a device to monitor cutaneous and ocular fundus blood flow. The aim of this study reveals that the differences…2020 American Transplant Congress
Tacrolimus Concentrations Are Associated with Measures of Body Composition in Adult Kidney Transplant Recipients
*Purpose: Tacrolimus (Tacro) is essential for kidney transplant immunosuppression but has a narrow therapeutic window. Tacro dosing preventing rejection must be balanced with potential delayed…2020 American Transplant Congress
What is the Significance of Denovo Donor Specific Antibodies in Recipients of Simultaneous Liver-Kidney Transplants?
University of Wisconsin, Madison, WI
*Purpose: There is limited information about the utility of donor-specific HLA antibody (DSA) testing and the role of protocol kidney biopsy for de-novo donor-specific antibodies…2020 American Transplant Congress
Optimal Timing of Initiating Continuous Renal Replacement Therapy in Patients with Acute Kidney Injury after Liver Transplantation
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Purpose: Acute kidney injury(AKI) is a frequent complication after liver transplantation(LT), and is associated with high mortality. Continuous Renal Replacement Therapy (CRRT) is a blood…2020 American Transplant Congress
Association with Acute Kidney Injury and Chronic Kidney Disease after Liver Transplantation
Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: Although early survival after liver transplantation (LT) has improved, late complications such as renal dysfunction have been discussed as a problem. Here, we have…2020 American Transplant Congress
Improvement of Renal Function Prior to Liver Transplantation is Not Associated with Better Long-Term Renal Outcome or Mortality
*Purpose: Since introduction of the MELD score in the liver allocation system, renal impairment in OLT recipients has become a topic of increasing importance. This…2020 American Transplant Congress
De Novo Use of Envarsus (LCPT) in African American and Elderly Kidney Transplant Recipients: An Early Single Center Experience
*Purpose: Clinical trials with LCPT have shown a steadier and more consistent concentration time profile over 24 hours with increased bioavailability compared to twice daily…
- « Previous Page
- 1
- …
- 501
- 502
- 503
- 504
- 505
- …
- 1683
- Next Page »
